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ABSTRACT Acinetobacter baumannii is a high-risk pathogen due to the rapid global
spread of multidrug-resistant lineages. Its phylogenetic divergence from other
ESKAPE pathogens means that determinants of its antimicrobial resistance can be
difficult to extrapolate from other widely studied bacteria. A recent study showed
that A. baumannii upregulates production of an outer membrane lipoprotein, which
we designate BonA, in response to challenge with polymyxins. Here, we show that
BonA has limited sequence similarity and distinct structural features compared to
lipoproteins from other bacterial species. Analyses through X-ray crystallography,
small-angle X-ray scattering, electron microscopy, and multiangle light scattering
demonstrate that BonA has a dual BON (Bacterial OsmY and Nodulation) domain
architecture and forms a decamer via an unusual oligomerization mechanism. This
analysis also indicates this decamer is transient, suggesting dynamic oligomerization
plays a role in BonA function. Antisera recognizing BonA shows it is an outer mem-
brane protein localized to the divisome. Loss of BonA modulates the density of the
outer membrane, consistent with a change in its structure or link to the peptidogly-
can, and prevents motility in a clinical strain (ATCC 17978). Consistent with these
findings, the dimensions of the BonA decamer are sufficient to permeate the pepti-
doglycan layer, with the potential to form a membrane-spanning complex during
cell division.
IMPORTANCE The pathogen Acinetobacter baumannii is considered an urgent threat
to human health. A. baumannii is highly resistant to treatment with antibiotics, in
part due to its protective cell envelope. This bacterium is only distantly related to
other bacterial pathogens, so its cell envelope has distinct properties and contains
components distinct from those of other bacteria that support its function. Here, we
report the discovery of BonA, a protein that supports A. baumannii outer envelope
function and is required for cell motility. We determine the atomic structure of BonA
and show that it forms part of the cell division machinery and functions by forming
a complex, features that mirror those of distantly related homologs from other bac-
teria. By improving our understanding of the A. baumannii cell envelope this work
will assist in treating this pathogen.
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A cinetobacter baumannii is a notorious “red alert” pathogen, considered an urgentthreat to human health by international infectious disease control agencies (1–4).
As a member of the gammaproteobacterial family Moraxellaceae, A. baumannii is ge-
netically and physiologically divergent from well-studied model Gram-negative
Enterobacteriaceae such as Escherichia coli. A. baumannii has a unique cell envelope
that protects it from disinfectants and desiccation that readily kill other bacterial spe-
cies, allowing it to persist for long periods on artificial surfaces in hospitals (5, 6). In
addition, A. baumannii is notorious for its innate and acquired antibiotic resistance (2).
It is currently estimated that as many as 50% of all A. baumannii infections in the
United States are caused by strains resistant to carbapenems and many strains acquire
polymyxin resistance during treatment (7, 8).
Like other Gram-negative bacteria, A. baumannii has a cell envelope consisting of
an inner and outer membrane. This dual membrane encloses the periplasm, a crowded
compartment that contains a thin layer of peptidoglycan (9). The outer membrane of
A. baumannii is an intricate structure, consisting of an asymmetric lipid bilayer with an
inner leaflet composed of phospholipids and an outer leaflet composed of lipooligo-
saccharide (LOS) (10). The LOS-derived surface of the outer membrane acts as a barrier
to hydrophobic molecules (11). In addition to LOS and phospholipids, the outer mem-
brane contains numerous proteins that are either integrated into or anchored in the
membrane (12).
To maintain the integrity of the outer membrane, Gram-negative bacteria actively
maintain its lipid asymmetry and coordinate its biogenesis rate with the overall rate of
cell growth. In addition, the outer membrane must be constricted in conjunction with
the peptidoglycan cell wall during division (13). To achieve this, Gram-negative bacteria
have evolved a network of interlinked pathways for the construction and maintenance
of the outer membrane (12, 14–22). Despite considerable progress in understanding
how these pathways function in E. coli, in many cases, the proteins that constitute them
are not well characterized, and additional pathways likely remain to be identified (12, 20, 23).
In species divergent from E. coli, such as A. baumannii, these knowledge gaps are much more
substantial.
Among these knowledge gaps is the role of dual-BON domain proteins, a widespread
family of outer envelope proteins in Gram-negative bacteria. Dual-BON family proteins
contain a pair of Bacterial OsmY and Nodulation (BON) domains, which fold into a con-
served a/b sandwich (24). They possess a signal peptide targeting them to the periplasm,
and some family members possess a lipobox with an N-terminal acylated cysteine, media-
ting peripheral outer membrane association (25, 26). They lack conserved residues indica-
tive of an enzyme active site, though some family members bind phospholipids (27).
Archetypical members of this dual-BON domain family are the outer membrane-associ-
ated lipid-binding protein DolP (formerly YraP) and the soluble periplasmic protein OsmY,
both of which play a role in the construction and maintenance of the bacterial outer en-
velope (25–29). OsmY is an abundant periplasmic protein in E. coli induced in response to
stressors such as osmotic shock, heat shock, acidic pH, and bile salts (25, 30). Recently, it
was shown that OsmY functions as a chaperone, enhancing the stability of periplasmic
proteins and the assembly of a subset of outer membrane proteins (31).
DolP is a lipoprotein widely present in Gram-negative bacteria. In E. coli and Neisseria men-
ingitidis, it localizes to the inner leaflet of the outer membrane via an N-terminal lipid anchor
(32–34). DolP was initially identified in E. coli as a lipoprotein whose expression is induced
under cell envelope stress and it forms part of the s E regulon (35). Mutants of E. coli, N. menin-
gitidis, and Salmonella enterica lacking DolP are compromised in outer membrane integrity,
rendering the cells more sensitive to agents like the detergent sodium dodecyl sulfate (SDS)
or the antibiotic vancomycin (26, 27, 29, 33, 35, 36). Possibly as a result of impaired
outer membrane integrity, loss of DolP leads to attenuation of virulence in rodent models of
infection (26).
There has been significant recent progress in determining the function of DolP in E. coli,
suggesting multifaceted roles in regulating cell division and aiding outer membrane protein
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insertion during protein folding stress (27, 29, 32); however, the mechanism by which DolP
mediates these functions remains to be elucidated. In E. coli, DolP is recruited to the site of
cell division through interaction with anionic phospholipids, mediated a-helix 1 of its C-ter-
minal BON domain (27, 32). This recruitment is required for the activation of cell wall remod-
eling enzymes during cell division, suggesting DolP has a regulatory role in this process (27,
32, 37). A recent study resolved the solution structure of DolP from E. coli, showing that it
conforms to a dual-BON domain architecture and is monomeric (27). However, analysis of
DolP isolated from E. coli membranes suggests that it forms oligomeric species (29).
Furthermore, DolP interacts transiently with the BAM complex, which is responsible for the
insertion of outer membrane proteins, and this interaction is important for coping with outer
membrane protein folding stress (29). DolP association with the BAM complex is inversely
correlated with localization to the site of cell division, suggesting a possible role for DolP in
linking outer envelope stress to septal peptidoglycan hydrolysis (29).
The focus of this study is a dual-BON domain protein synthesized by A. baumannii.
Previous work has shown that this bacterium can become resistant to the LOS-binding
antibiotic polymyxin through mutations that prevent LOS production (38). These
mutants survive with an outer membrane where phospholipids compose the only lipid
species in both leaflets of the membrane (38). In both wild-type polymyxin-treated
cells and polymyxin-resistant LOS-deficient mutants, a dual-BON domain family lipo-
protein protein (HMPREF0010_02957 and ABBFA_002498) is upregulated (39, 40). This
suggests that this protein, which we designate BonA, plays a role in adaption to the
effects of polymyxin on the A. baumannii outer envelope and to the loss of LOS. BonA
is only distantly related to either DolP or OsmY and we show that, unlike DolP, its loss
in A. baumannii does not lead to a gross outer membrane permeability defect.
However, A. baumannii mutants lacking BonA have an altered outer membrane struc-
ture and a defect in cell motility. Like DolP, single-cell imaging of A. baumannii indi-
cates that BonA is localized to the divisome. However, BonA lacks conserved amino
acids that mediate phospholipid binding by DolP (27), suggesting anionic phospholi-
pids may not drive this localization. Through structural and biophysical analysis, we
show that BonA forms a decamer and that this oligomerization is stabilized by a novel
mechanism, involving rearrangement of the BON domain fold. Further, we show that
BonA extracted from cell membranes is oligomeric and that the stability of the BonA
oligomer is important for function in A. baumannii. Based on its unique structure,
dynamic oligomerization, and role in optimal outer membrane function, we have iden-
tified BonA as an important component of the A. baumannii outer envelope.
RESULTS
BonA from A. baumannii is a member of a diverse family of dual-BON domain
outer membrane lipoproteins. Analysis of A. baumannii genomes showed that they
encode only one BON domain family protein, and sequence analysis of this lipoprotein
suggests dual-BON domains, a terminal lipobox with an acyl-anchoring cysteine resi-
due, and N- and C-terminal extensions (Fig. 1A). BonA shows substantial sequence
divergence from DolP from E. coli (23% amino acid identity) and Neisseria spp. (24%
identity) and is even more distantly diverged from OsmY from E. coli (20% identity)
(see Table S1 in the supplemental material). A phylogenetic tree confirmed the distant
evolutionary relationship between BonA and other dual-BON domain lipoproteins
identified in a HMMER search of the reference proteome database (Fig. 1B; see also
Table S1) (41). BonA belongs to a distinct clade clustering with proteins from other spe-
cies of the family Moraxellaceae. A C-terminal proline-rich extension is present in BonA
and other related sequences from Acinetobacter and Moraxella species but is absent
from DolP and OsmY (Fig. 1A; see also Fig. S1).
BonA is localized to the divisome and its deletion prevents motility. The distant
evolutionary relationship between BonA and other dual-BON family proteins poses the
question of whether these proteins share a conserved function. To address this, we
sought to determine the subcellular localization and physiological role of BonA.
Mutants of the well-characterized A. baumannii type strain ATCC 19606 and clinical
BonA from Acinetobacter baumannii ®

























































isolate ATCC 17978 were constructed (DbonA). Antibodies raised to BonA detected the
protein in wild-type A. baumannii ATCC 19606, but not in the DbonA strain, when
membrane extracts were analyzed by SDS-PAGE and immunoblotting (Fig. 2A). BonA
was not detected in soluble cell extracts after ultracentrifugation, indicating it is
FIG 1 Sequence, secondary structure, and molecular phylogeny of BonA. (A) Amino acid sequence of BonA showing secondary
structure (b-sheet = blue arrows, a-helix = green spirals; predicted or based on the BonA-27N crystal structure), the location of
BON1 (light blue) and BON2 (dark blue), and regions largely lacking predicted structure (purple) and the signal peptide (gray) and acyl-
anchored cysteine (red). Amino acids present in BonA-27N are underlined, solid for those resolved in the crystal structure, and dashed for
disordered regions. (B) Maximum-likelihood phylogenetic tree of BonA homologs (shown in Table S1), showing the relatedness of BonA to
the characterized family member DolP from E. coli and N. meningitidis. The clade containing the distinct dual-BON domain family member
OsmY from E. coli was used to root the tree. Nodes are color-coded according to bootstrap values based on 100 replicates.
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entirely membrane-associated (see Fig. S2A). Upon Western blotting of BonA from
membrane extracts, we noted multiple bands corresponding to the protein (Fig. 2A).
This pattern is reminiscent of proteins modified by O-linked glycosylation mediated by
the enzyme PglL, which glycosylates serine residues in motifs similar to those in the
BonA C-terminal extension (see Fig. S1) (42, 43). To test whether O-linked glycosylation
was present, we analyzed cell extracts from wild-type A. baumannii ATCC 17978 and a
pglL deletion mutant (DpglL). In both strains the patterns of BonA on SDS-PAGE were
analogous, suggesting that PglL does not glycosylate BonA (see Fig. S2B). The pattern
of electrophoresis observed for BonA may be due to an unknown posttranslational
modification or to proteolytic processing of the protein. To monitor the subcellular
localization of BonA, cell membrane extracts were fractionated via a sucrose gradient,
followed by immunoblotting, revealing that BonA colocalizes with the outer mem-
brane porin Omp38 and not the inner membrane NADH-quinone oxidoreductase sub-
unit NuoG (Fig. 2D; see also Fig. S2C).
While the relative abundance of proteins present in A. baumannii ATCC 19606
DbonA membranes was similar to the wild type, the outer membrane fraction from the
DbonA strain progressed further into the sucrose gradient. This suggests that its struc-
ture or composition is altered, leading to an increase in density (Fig. 2D). No significant
increase in sensitivity to SDS, vancomycin, or tetracycline was observed in the DbonA
strain (see Table S2), suggesting that loss of BonA does not impair the integrity of the
outer membrane in A. baumannii. A common phenotype for surface defects in A. bau-
mannii is loss of motility on a swarm plate: while A. baumannii lacks flagella, twitching
motility is observed in some strains of this species, thought to be mediated by the
type IV pilus (44). Type IV pili are dynamic protein filaments that are assembled and
secreted from the cell via a large protein complex that spans the bacterial cell enve-
lope (45). ATCC 19606 is nonmotile, so this phenotype could not be tested in this strain
(see Fig. S2D); however, loss of motility was observed in the A. baumannii ATCC 17978
FIG 2 Cellular localization of BonA and phenotypes associated with loss of BonA in A. baumannii. (A) SDS-
PAGE Western blot of total cellular membranes from wild-type and DbonA A. baumannii ATCC 19606 with an
anti-BonA antibody, showing that BonA is membrane localized. (B) Blue-native PAGE Western blot of
membranes as in panel A, showing BonA adopts a dimer and higher-molecular-weight species when purified
from native membranes. (C) Immunofluorescence microscopy of wild-type and DbonA A. baumannii ATCC
19606 using an anti-BonA antibody, showing BonA is localized to the site of cell division; Scale bar, 2mm. Cell
outlines are traced to illustrate the cell division stage. (D) Coomassie blue staining and anti-BonA Western blot
of SDS-PAGE of sucrose gradient separated of membranes from panels A and B showing that BonA is
associated with fractions containing the outer membrane and that, in the DbonA strain, the outer membranes
exhibit a higher density on the sucrose gradient. A difference between wild-type and DbonA mutant outer
membrane densities was observed in four separate fractionation experiments, with the results of one
representative experiment shown. (E) Semisolid motility assay plates of A. baumannii ATCC 17978, showing that
the DbonA is nonmotile compared to the wild type and the complemented mutant, where expression of BonA
from pWH1266 restores this phenotype.
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DbonA strain, which could be complemented by the addition of bonA in trans (Fig. 2E).
The loss of twitching motility observed in the ATCC 17978 DbonA mutant suggests
that BonA plays either a direct or indirect role in the assembly or maintenance of the
motility machinery.
Like BonA, DolP is a lipoprotein anchored to the outer membrane. DolP localizes to
the divisome where it plays a role in regulating peptidoglycan remodeling during cell
division (32). To determine whether BonA shares a common localization, we used the
antibodies to monitor BonA in single cells via immunofluorescence microscopy.
Consistent with localization to the divisome, fluorescence corresponding to BonA was
observed as a central band in what appeared to be elongated, early-stage dividing
cells. This band constricted in concert with the cell division septum (Fig. 2C; see also
Fig. S3). No fluorescence beyond background was observed in DbonA cells (Fig. 2C; see
also Fig. S3). To investigate the native structure of BonA, membrane extracts were solu-
bilized in detergent and analyzed by blue-native PAGE. The vast majority of BonA was
detected at a molecular weight of ;60 kDa (Fig. 2B). Longer exposure of the immuno-
blots revealed a smaller proportion of BonA was detected as a larger oligomeric spe-
cies (250 to 300 kDa) (Fig. 2B).
Crystal structure of BonA. To gain insight into the structural organization of BonA,
as well as its architecture at the outer membrane, we solved its crystal structure. Crystal
trials were performed with full-length BonA, as well as several truncation constructs. High-qual-
ity crystals were only obtained for N-terminally truncated BonA, missing the 27 amino acids
(aa) after its lipid-anchoring cystine. The structure of this protein, designated BonA-27N, was
solved at 1.65Å by single-wavelength anomalous dispersion (SAD) phasing, using selenome-
thionine labeled protein. The structure of BonA-27N was built and refined from the resulting
electron density maps (Fig. 3A; see also Table S3). The crystal structure of BonA-27N consists
of two a/b-sandwich BON domains that interact extensively via the external face of their
three-strand b-sheets (Fig. 3A). In contrast to the structure of DolP in which both domains
adopt a canonical BON domain fold (27), in the BonA structure, a-helix 1 (aH1) of BON do-
main 1 (BON1) does not adopt the expected BON domain conformation of running parallel to
the BON domain b-sheet. Rather, it is displaced from the rest of the domain (Fig. 3A). The 39
aa of the C-terminal extension of BonA-27N (aa 196 to 235) are disordered in the crystal
structure. This region of BonA is not present in DolP or OsmY and is predicted to be largely
unstructured (Fig. 1A; see also Fig. S1).
Analysis of BonA-27N crystallographic symmetry reveals that it exists as a dimer,
aligned with the crystallographic 2-fold axis (Fig. 3B). Analysis with the molecular inter-
face prediction tool PISA (46) predicts that this interface is bona fide. The symmetrical
BonA-27N dimer interacts via an extensive interface encompassing both BON domains
(Fig. 3B). The interface is stabilized by aH1 of BON domain 2 (BON2), which substitutes
for the displaced aH1 of BON1, thus completing the a/b-sandwich fold of BON1
(Fig. 3C). This interaction of aH1 of BON2 with BON1 is largely mediated by hydropho-
bic interactions (Fig. 3D), with Tyr118 and Met122 of aH1 of BON2 extending deeply
into a hydrophobic pocket created by the displacement of aH1 of BON1 (Fig. 3E).
While the interactions between aH1 of BON2 and BON1 are largely hydrophobic, the
dimer interface of BonA-27N is mediated by a mixture of interaction types, including
14 hydrogen bonds and four salt bridges (Fig. 3F). The interface also contains two sym-
metrical, highly solvated pockets, which trap a total of 34 water molecules, as well as
two Zn21 ions which were present at a high concentration in the crystallization solu-
tion (Fig. 3G). In DolP from E. coli, aH1 of BON2 is responsible for binding to anionic
phospholipids present in the outer membrane, with lipid binding mediating the divi-
some localization of DolP (27). In the BonA-27N structure, aH1 of BON2 is largely bur-
ied at the dimer interface and would be unable to access lipids. Further, BonA lacks
conserved residues present in this helix of DolP required for lipid binding (27). This
suggests that BonA localizes to the divisome by some other means.
A recent study by Wu et al. supports the physiological relevance of the BonA dimer,
demonstrating via a global proteomic approach that interaction occurs between BonA
Grinter et al. ®

























































FIG 3 The crystal structure of BonA-27N reveals a dual-BON domain architecture that dimerizes via
an a-helix swap mechanism. (A) The crystal structure of BonA-27N shown as a rainbow cartoon N
terminus (blue) to C terminus (red) displays a dual-BON domain architecture with displaced a-helix 1
(aH1) of BON domain 1. (B) Dimer of BonA-27N observed in crystallo. (C) A key interface of the BonA-
27N dimer involves the displacement of aH1 of BON1 by a-helix 1 (aH1) of BON2 of the opposing
BonA molecule. aH1 of BON2 is amphipathic and interacts with the opposing molecule largely
through hydrophobic interactions shown in panels D and E. As shown in panels F and G, the BonA
dimer interface consists of both hydrophobic and polar interactions and is highly solvated.
BonA from Acinetobacter baumannii ®

























































molecules in A. baumannii cells (47). This study identified intermolecular cross-links
between lysines 50, 59, and 65 of neighboring BonA molecules in A. baumannii cells. In
the BonA-27N structure, lysines 59 and 65 are located in aH1 of BON1 and are within
proximity to their dimer equivalent in our BonA-27N structure (see Fig. S4). Lysine 50 is
unresolved in the crystal structure, but given this region of BonA is crucial for oligome-
rization, it is also a plausible candidate for cross-linking based on our data.
BonA decamerizes under physiological conditions through interactions mediated
by its N-terminal extension. Our structural and biochemical analysis indicated that
BonA oligomerizes in A. baumannii cells and as a recombinant protein. To investigate
the oligomeric state of BonA, the mature recombinant protein (lacking its signal
sequence) was analyzed by size exclusion chromatography (SEC). In the absence of de-
tergent, BonA migrated predominately as a high-molecular-weight species, with some
disassociation to a lower-molecular-weight species observed. To gain a more precise
understanding of the molecular weight of this oligomer, purified BonA was analyzed
by analytical ultracentrifugation, revealing the presence of a single species with a mo-
lecular mass of ;240-kDa (see Fig. S5A). The molecular mass of the BonA oligomer was
confirmed by size exclusion chromatography coupled multiangle laser-light scattering
(SEC-MALS), which indicated this species has a molecular mass of 233 kDa, which is
consistent with a decamer, while the smaller species has a mass of 23 kDa, correspond-
ing to a BonA monomer (Fig. 4B). To determine whether the N- or C-terminal exten-
sions flanking the core BonA BON domains were responsible for oligomerization, trun-
cation constructs lacking the N-terminal 27 aa succeeding the lipobox and/or the
C-terminal 45 aa were analyzed via SEC-MALS (Fig. 1A and 4A). Removal of the C-termi-
nal extension increased the tendency of BonA to aggregate but did not affect the oli-
gomeric state of the protein, with a decamer of 205 kDa observed for the truncated
protein (Fig. 4C). Conversely, loss of the 27 N-terminal amino acids abrogated oligome-
rization, with only a monomeric species of ;22 kDa observed (Fig. 4D). Loss of both
the N- and C-terminal regions also resulted in a monomeric protein, further confirming
the role of the N terminus of BonA in oligomerization (Fig. 4E). In conclusion, BonA
forms a decamer that requires its N-terminal extension and undergoes spontaneous
disassociation into a monomeric species in solution. The monomeric nature of BonA-
27N in solution contrasts with the dimer observed in its crystal structure, suggesting
that weak interactions between monomers of this truncated protein are selected for
during crystallization.
To understand the basis of oligomerization of BonA, both full-length and BonA-27N
were analyzed via size exclusion coupled small-angle X-ray scattering (SEC-SAXS) (see
Fig. S5; see also Table S3). Despite the C-terminal extension, which largely lacks pre-
dicted secondary structure and was disordered in the BonA-27N crystal structure, SAXS
scattering indicates that decameric BonA forms a compact particle in solution with
maximum dimensions of ;164Å (see Fig. S5F and G). In contrast, SAXS scattering indi-
cates that BonA-27N is highly flexible in solution with maximum dimensions of 107 Å,
which is indicative of an unstructured and fully extended C terminus (see Fig. S5J and
K). These differences between decameric and monomeric BonA suggest that intermo-
lecular interactions stabilize the C terminus of the oligomeric form of the protein.
Molecular envelopes of full-length and BonA-27N were modeled based on SAXS
scattering data. For full-length BonA, C5 symmetry was imposed, based on the deca-
meric organization of the oligomer and the dimer observed in the crystal structure.
The resulting molecular envelope was prolate, with dimensions of ;172 by 102Å. Five
dimers of the BonA-27N crystal structure could be modeled with C5 symmetry into a
bulge at the center of the envelope. The N and C termini of all molecules are orien-
tated in the same direction, which is required by the lipid anchored N terminus of
BonA. Regions truncated or disordered in the BonA-27N crystal structure could be
accommodated by the remainder of the molecular envelope (Fig. 4F). The molecular
envelope of BonA-27N was indicative of a monomer, with dimensions of ;133 by 40 Å.
The crystal structure of BonA-27N could be modeled into a bulge at one end of the en-
velope, with additional space accounting for the unstructured C-terminal extension
Grinter et al. ®

























































FIG 4 BonA forms a decamer with pentameric symmetry mediated by its N terminus. (A) A cartoon
schematic of BonA showing its two central BON domains, with N- and C-terminal extensions with
(Continued on next page)
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(Fig. 4G). The simulated scattering curves for both envelopes were an excellent fit for
the experimental data (Fig. 4H).
To validate the SAXS-based modeling of the BonA decamer, we further investigated
BonA via negative-stain electron microscopy (NS-EM). Initial analysis of EM grids pre-
pared with native BonA did not contain discrete particles. To stabilize the decamer, on-
column glutaraldehyde cross-linking was performed, stabilizing BonA as first a dimeric
and then a decameric species with increasing glutaraldehyde concentration (see
Fig. S5B). NS-EM of the cross-linked sample revealed largely uniform monodisperse par-
ticles (see Fig. S5C). Two-dimensional (2D)-class averages derived from these images
are suggestive of a particle with dimensions compatible with the BonA SAXS envelope
and C5 symmetry, as predicted by other analyses (Fig. 4I).
Disruption of the BonA dimer interface destabilizes the decamer and affects
protein function. To gain insight into the role of the BonA dimer in stabilizing the dec-
amer, we expressed and purified a series of BonA variants with amino acid substitu-
tions in hydrophobic residues of aH1 of BON2 that form part of the dimer interface
(Fig. 5A). Two double substitutions (Y118S/A2125D and M122D/A129D) and one quin-
tuple substitution (Y118S/I121D/M122D/A125D/A129D) were generated to maximize
disruption of the BonA dimer interface. All mutant variants expressed and purified as
the wild type, predominately decameric species were observed, with an increase in the
amount of monomer present in all mutants. Wild-type and mutant BonA variants were
purified concurrently and the decameric species were isolated and incubated for 0, 24,
or 72 h at room temperature before the rate of decamer disassociation was monitored
by SEC. All mutants displayed a higher rate of disassociation than the wild type, indi-
cating that disruption of the BonA dimerization interface also partially destabilizes the
BonA decamer (Fig. 5B; see also Table S4). The lack of total disruption of the decamer
in the BonA mutants is consistent with the role of the BonA N-terminal extension in
decamerization. The stability of the wild-type and BonA decamers was also tested using
differential scanning fluorimetry and light scattering. Wild-type BonA fluorescence exhibited
two inflection points at 54.3 and 60.5°C, the latter corresponding to an increase in light scatter-
ing indicating protein denaturation, with the former likely corresponding to decamer disassoci-
ation (Fig. 5C; see also Table S4). Inflection point 1 was shifted compared to wild type by 29
and 27°C for the Y118S/A2125D and M122D/A129D mutants, respectively, further indicating
destabilization of the decamer in these mutants. Inflection point 1 was not observed for the
quintuple mutant, and inflection point 2 was shifted by 210.4°C, indicating this mutant was
further destabilized (Fig. 5C; see also Table S4).
To assess the effect of mutations on the function of BonA in A. baumannii, wild-
type and mutant BonA constructs were introduced into the A. baumannii ATCC 17978
DbonA strain. The multiple copies of the complementation plasmid meant all comple-
mented strains produced more BonA than wild-type A. baumannii ATCC 17978 (Fig. 5D
and E). The migration pattern of the mutant BonA variants on blue-native PAGE was
distinct from the wild-type complement strain, with a compact BonA species present
at ;66 kDa and less-diffuse species present at ;240 kDa. However, the profile of the
BonA mutants was more similar to that of the uncomplemented wild-type strain in this
experiment, making the significance of these differences difficult to interpret. Interestingly,
FIG 4 Legend (Continued)
limited predicted secondary structure. (B and C) SEC-MALS experiments showing that full-length
soluble BonA (B) and a 45-aa C-terminally truncated variant (C) are predominantly decamers, with
some disassociation into a monomer. Conversely, 27-aa N-terminally truncated (D) and 45-aa C and
27-aa N-terminally truncated (E) variants both are monomers. (F) Bead model of the full-length BonA
decamer modeled from SAXS data with C5 symmetry imposed (top), and a mesh representation of
this bead model with the BonA-27N dimer structure modeled consistent with the observed
decameric oligomerization (bottom). (G) Bead model of the BonA-27N monomer modeled from SAXS
data (top), and a mesh representation of this bead model with monomer BonA-27N structure
modeled. (H) SAXS scattering curves for full-length BonA (top) and BonA-27N (bottom) in black, with
simulated scattering curves for the bead models in panels F and G shown in green. (I) Class averages
generated from negative stain EM images of the cross-linked BonA decamer showing a pentameric
organization; Scale bar, 100 Å.
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in all complemented strains a diffuse higher-order species at;1,000kDa was observed, sug-
gesting BonA is present in a larger oligomer or complex (Fig. 5D). As a readout for BonA
functionality, the swarming motilities of wild-type, DbonA, and complemented strains were
assessed (Fig. 5F). While motility was restored in A. baumannii ATCC 17978 DbonA comple-
mented with wild-type BonA, none of the mutant BonA variants complemented the motility
defect, indicating these variants have compromised functionality and that BonA oligomeriza-
tion is important for function.
DISCUSSION
In this work, we identify BonA, a member of the bacterial dual-BON domain family
of proteins, produced by A. baumannii and encoded by other members of the family
Moraxellaceae. We demonstrate that BonA is anchored to the outer membrane where
it plays a role in maintaining membrane structure and is required for twitching motility.
Through structural analysis, we show that BonA possesses unique structural features
and forms a divisome localized decamer that is important for the protein’s function
(Fig. 6). We show that while BonA shares a common outer membrane and divisome
localization to DolP from E. coli and Neisseria spp. (26, 28, 35), its loss does not lead to
FIG 5 Dimer interactions mediated by BonA aH1 of BON2 are important for decamer stability and function in cells. (A) Amino acids of aH1 of BON2,
shown as purple sticks, that form key hydrophobic interactions with the opposing molecule of the BonA dimer, shown as a white molecular surface. (B)
SEC analysis of purified wild-type and mutant BonA at 0, 24, and 72 h postpurification, showing increased decamer dissociation of the mutants (monomer
to decamer ratios shown in Table S4). (C) Differential scanning fluorimetry and light scattering of purified wild-type and mutant BonA as a function of
temperature, showing first derivative transitions in the BonA 330/350-nm fluorescence ratio (top) and light scattering (bottom), indicating structural
transitions of the protein. (D) Blue-native PAGE Western blot detecting BonA species in the membrane fraction of wild-type, DbonA, and wild-type and
mutant BonA complemented strains. The lane designated WT* shows a longer exposure to visualize BonA in this sample. (E) SDS-PAGE Western blot
detecting BonA in samples from panel D. (F) Semisolid motility assay plates of A. baumannii ATCC 17978, showing that complementation of the DbonA
strain with of wild-type bonA restored the motility phenotype but complementation with the mutant variants does not.
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the gross defects in outer membrane permeability observed in DolP deletion mutants
of these species. Further, purified DolP is monomeric and its divisome localization is
mediated by phospholipid binding, while BonA is a decamer that lacks the conserved
lipid-binding residues found in DolP (27). Analysis of DolP from E. coli membranes
indicates it forms diffuse oligomers that echo those observed in membrane-derived
BonA (29). However, whether the oligomerization mechanism we demonstrate for
BonA extends to DolP and whether the conformation of monomeric BonA is analo-
gous to DolP remain to be determined. Furthermore, whether, like DolP, BonA
interacts transiently with the BAM complex to mitigate protein folding stress is an
interesting question for future study (29).
The change in outer membrane density associated with the loss of BonA suggests a
significant alteration in the structure or composition of this membrane or the physical
membrane-peptidoglycan links. Consistent with this, the loss of twitching motility
observed in the A. baumannii ATCC 17978 DbonA mutant, likely mediated by an outer-
envelope spanning type IV pilus (44), is suggestive of a perturbed outer envelope.
These data are also consistent with our previous finding that BonA is upregulated in
response to outer membrane destabilizing polymyxins (38, 39) and broadly indicate a
role for BonA in supporting optimal outer membrane function.
While further work is required to determine the precise role of BonA in the outer
membrane, our structural analysis provides important insights into BonA function. We
show that BonA forms a decamer that is ;172Å in length. In the context of the peri-
plasmic space, where the nominal distance between the outer and inner membranes is
;200Å (48), outer membrane-anchored BonA would span the majority of the peri-
plasm if extending perpendicular from the membrane (Fig. 6). In this configuration,
BonA would penetrate the peptidoglycan layer and would be capable of interacting
with proteins embedded in the inner membrane, thus bridging the inner and outer
membranes. When localized to the site of cell division, BonA could tether the outer
membrane to the peptidoglycan or the membrane-spanning divisome complex
(Fig. 6). In support of this hypothesis, in-cell cross-linking data show interactions occur
between BonA and OmpA in A. baumannii (47), with OmpA playing a role in tethering
the outer membrane to the peptidoglycan (49). The transient nature of BonA oligome-
rization is also consistent with a role in coordinating a dynamic process during cell divi-
sion. If BonA is indeed important for coordinating the outer envelope during cell
FIG 6 Model of BonA localization, oligomerization, and potential function at the outer membrane.
BonA is anchored to the periplasmic side of the outer membrane, where it forms a transient decamer
that spans the majority of the periplasmic space. BonA is recruited to the site of cell division, where it may
interact with the peptidoglycan and act as a membrane-spanning scaffold for divisome proteins.
Grinter et al. ®

























































division, its loss would lead to improper remodeling of this structure, which is consist-
ent with the DbonA phenotypes we observe.
The cell envelope provides a key defense for A. baumannii against antimicrobial
compounds and environmental stress. To effectively combat A. baumannii infection
and its persistence in the hospital environment, we must develop strategies to over-
come the outer envelope’s defenses. To do so, a robust understanding of the key fac-
tors required for outer membrane construction and maintenance is required. Our work
on BonA informs this understanding and provides insights into the role of this protein
in supporting outer membrane function in A. baumannii.
MATERIALS ANDMETHODS
Protein sequence analysis. To determine the relationship between distantly related dual-BON do-
main family members, we constructed a tree of BonA homologs, identified with a HMMER search of the
reference proteomes database using BonA as a query sequence (41). BonA homologs identified in the
HMMER search were curated to only include proteins with a dual-BON domain architecture and a lipo-
box sequence determined using SignalP 5.0 (50). This yielded 896 sequences, which were further
reduced for tree construction using CD-Hit to filter sequence with a pairwise similarity of,75%, yielding
565 sequences (see Table S1) (51). These 565 protein sequences, plus OsmY from E. coli as a sequence to
define the root branch, were aligned using MUSCLE (52) implemented in the phylogenetic analysis pro-
gram MEGAX (v.10.1.7) (53), which was subsequently used as the input for constructing a maximum-like-
lihood (ML) phylogenetic tree to infer evolutionary relationships for this protein family. The best amino
acid substitution model was inferred using MEGAX which compared 56 different models; the Jones-
Taylor-Thornton model with a gamma distribution of five discrete gamma categories and invariant sites
(G1I) was selected. To infer tree topology, the default ML heuristic method ML nearest-neighbor-inter-
change was applied, and initial trees were made with Neighbor-Joining and BioNJ algorithms. The final
tree was built by including all residues and bootstrapping with 100 replicates.
Strain propagation, maintenance, and antimicrobial susceptibility testing. E. coli and A. bau-
mannii strains were propagated in lysogeny broth (LB) and LB agar at 37°C, with antibiotic selection to
maintain plasmids where appropriate. Antimicrobial susceptibility was conducted per CLSI guidelines
using the broth microdilution method and cation adjusted Muller Hinton broth. MICs were defined as
.80% reduction in growth, and significance considered as .2 concentration increase or decrease in
MIC relative to the wild-type control.
Construction of DbonA strains in A. baumannii. Plasmid DNA, genomic DNA, and PCR products were
purified using relevant kits from Bioneer, Qiagen, and Promega, respectively, according to the manufac-
turers’ instructions. The A. baumannii DbonA mutants were constructed as described previously (54), with
minor modifications. Briefly, the kanamycin resistance cassette was PCR amplified from pKD4 using disrup-
tion primers containing.80 bases of homology to the bonA flanking sequence (as described in Table S5 in
the supplemental material). The resultant fragments were gel purified and introduced into A. baumannii
strains ATCC 17978 and ATCC 19606 by electroporation as previously described (55), with selection on LB
agar, supplemented with 50mg/ml kanamycin. The mutations were confirmed by PCR amplification using
primers flanking the insertion, followed by Southern hybridization of genomic DNA digested with EcoRV,
probed with kanamycin- and bonA-specific digoxigenin-labeled probes, as described previously (56).
For complementation, the full-length bonA sequence plus 500 nucleotides upstream of the transla-
tional start site (deemed to include the native promoter) were PCR amplified from ATCC 17978 with for-
ward and reverse complementation primers encoding 59 AatII and EcoRI restriction sites, respectively.
The resultant fragments were digested and ligated into the E. coli-Acinetobacter shuttle vector,
pWH1266 (57). To create Y118S/A125D, M122D/A129D, and Y118S/I121D/M122D/A125D/A129D mutant
BonA complementation constructs, gene blocks identical to the PCR-amplified sequence, aside from the
stated mutations, were synthesized and cloned into pWH1266. The pBonA wild-type and mutant con-
structs were confirmed by sequencing before electroporation into the respective mutant strains as
described previously, with the pWH1266 vector-only used as a control.
Twitching motility assays. Twitching motility was assessed as described previously (44). Briefly, a 1-
ml drop of stationary-phase culture was placed onto the center of a 0.25% modified LB agarose and incu-
bated at 37°C for up to 48 h. Three independent experiments were performed for each.
BonA antiserum generation. Polyclonal rabbit antiserum for the detection of BonA was generated
at the Monash Animal Research Platform from recombinant proteins purified in-house. Rabbits were seri-
ally injected with purified protein (10mg/ml) in combination with complete (first injection) or incom-
plete (subsequent injections) Freund adjuvant, over 1 to 3months, with clarified rabbit sera periodically
tested for reactivity to the target protein. Once acceptable levels of reactivity were achieved, rabbits
were euthanized, and clarified sera were collected and stored at280°C.
Isolation and fractionation of membranes from A. baumannii. A. baumannii cells were cultured in
LB media and grown to an optical density at 600 nm (OD600) of ;0.6 before harvesting. Membranes
were purified and subsequently fractionated by sucrose density fractionation (60:55:50:45:40:35% [wt/
wt]) as described previously (58).
Detection and localization of BonA in A. baumannii cell extracts by Western blotting. For the
detection of BonA in cell extracts, 50-mg portions of isolated total membranes were analyzed by 10%
SDS-PAGE or 5 to 16% blue-native (BN)-PAGE (59) and was subsequently analyzed by Western blotting
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against BonA (antibody dilution, 1:20,000). To determine the cellular localization of BonA, 30-ml aliquots
of each fraction from the sucrose gradient were separated by 10% SDS-PAGE for Coomassie blue stain-
ing and subsequent Western blotting as described above.
Localization of BonA in A. baumannii cells by immunofluorescence microscopy. Bacterial cultures
were grown to mid-log phase in LB media at 37°C with shaking (200 rpm). Then, 500ml of culture medium
was centrifuged (4,000 g, 5min, 4°C), washed twice in phosphate-buffered saline (PBS), and resuspended
in 500ml of PBS. Eight-well, coverglass-bottom chambers (Sarstedt) were coated with 0.01% (vol/vol) poly-L-
lysine (Sigma-Aldrich, P8920) for 10min at room temperature before excess poly-L-lysine was removed.
Afterward, 200ml of bacterial cell suspension was immobilized onto each well. To ensure a monolayer of
bacteria was formed at the bottom of each well, chamber slides were subjected to centrifugation
(4,000 g, 3min, 4°C), followed by several washing steps to remove nonadhered cells. The monolayer of
bacteria was then fixed with a mixture of paraformaldehyde (2% [wt/vol]) and glutaraldehyde (0.2% [vol/
vol]) in PBS for 5min at 4°C, which was then washed with PBS to remove excess fixatives. To reduce auto-
fluorescence caused by the background, samples were treated with the fluorescence quencher NaBH4 at a
concentration of 0.1% (wt/vol) in PBS, followed by several washing steps with PBS. Samples were then per-
meabilized with Triton X-100 (0.001% [vol/vol] in PBS), followed by three washing steps with PBS.
Before antibody staining, samples were blocked with 5% (wt/vol) bovine serum albumin (BSA) in
PBS for 1 h at room temperature, followed by incubation with anti-BonA antisera (1:1,000 in 5% [wt/vol]
BSA in PBS) for 1-h mixing by rotary inversion at room temperature. Samples were washed thoroughly
with PBS to remove excess antiserum. Secondary staining was carried out for 45 min at room tempera-
ture using anti-rabbit immunoglobulin G (IgG)-Alexa Fluor 488 (Thermo Fisher, A-11008) diluted to
1:3,000 (in 5% BSA in PBS), followed by several washing steps to remove excess antibody. Olympus IX-81
inverted fluorescence microscope equipped with Olympus Cell˄M software was used to visualize bacte-
rial samples using a 100 objective with a fluorescein isothiocyanate filter.
Protein expression and purification. DNA encoding full-length BonA and BonA-C45 were amplified
by PCR, with C-terminal NcoI and XhoI restriction sites and cloned into a pET20b derived vector which
added a 10 N-terminal His tag, followed by a TEV cleavage site, via restriction digest and ligation. Gene
blocks encoding Y118S/A125D, M122D/A129D, and Y118S/I121D/M122D/A125D/A129D mutant full-
length bonA constructs were synthesized and cloned into the modified pET20b derived vector as for the
wild-type protein. The resulting vector was transformed into E. coli BL21(DE3) C41 cells. DNA encoding
BonA-27N and BonA-27N-45C were amplified by PCR, minus stop codon, with C-terminal NdeI and XhoI
restriction sites and cloned into pET22b vector which added a 6 C-terminal His tag. The resulting vec-
tors were transformed into E. coli BL21(DE3) C41 cells. Protein expression was performed in terrific broth
(12 g tryptone, 24 g yeast extract, 61.3 g K2HPO4, 11.55 g KH2PO4, 10 g glycerol) with 100mg/ml ampicil-
lin for selection. Cells were grown at 37°C until they reached an OD600 of 1.0 induced using 0.3mM IPTG
(isopropyl-b-D-thiogalactopyranoside), followed by further growth 14 h at 25°C. For selenomethionine-
labeled BonA-27N, the BonA-27N construct was transformed into the methionine auxotrophic E. coli
strain Crystal Express (DE3). Cells were grown in M9 minimal medium containing 100mg/liter of each
amino acids (minus methionine) and 50mg/liter selenomethionine. Cells were harvested by centrifuga-
tion, lysed using a cell disruptor (Emulsiflex) in Ni-binding buffer (50mM Tris, 500mM NaCl, 20mM imid-
azole [pH 7.9]) plus 0.1mg/ml lysozyme, 0.05mg/ml DNase I, and cOmplete protease cocktail inhibitor
tablets (Roche). The resulting lysate was clarified by centrifugation and applied to Ni-agarose resin, fol-
lowed by washing with 10 column volumes of Ni-binding buffer, and elution of bound proteins with a
step gradient of Ni-gradient buffer (50mM Tris, 500mM NaCl, 500mM imidazole [pH 7.9]) of 5, 10, 25,
and 50%. Eluted fractions containing recombinant protein were pooled and applied to a 26/600
Superdex S200 size exclusion column equilibrated in SEC buffer (50mM Tris, 200mM NaCl [pH 7.9]). The
recombinant protein was then pooled concentrated to 10mg/ml, snap-frozen, and stored at280°C.
Size-exclusion chromatography multiangle light scattering. The absolute molecular masses of
BonA-FL and truncated variants were determined by SEC-MALS. First, 100-ml protein samples (1 to 5mg/ml)
were injected onto a Superdex 200 10/300 GL size exclusion chromatography column in 20mM Tris–200mM
NaCl (pH 7.9) at 0.6ml/min with a Shimadzu LC-20A. The column eluent was fed into a DAWN Heleos II MALS
detector (Wyatt Technology), followed by an Optilab T-rEX differential refractometer (Wyatt Technology). Light
scattering and differential refractive index data were collected and analyzed using ASTRA 6 software (Wyatt
Technology). Molecular masses and estimated errors were calculated across individual eluted peaks by extrapo-
lation from Zimm plots with a refractive index increment (dn/dc) value of 0.1850ml/g. SEC-MALS data are pre-
sented with the absorbance (280nm) plotted alongside fitted the molecular masses (Mr).
Analytical size exclusion chromatography of wild-type mutant BonA. Wild-type and Y118S/
A125D, M122D/A129D, and Y118S/I121D/M122D/A125D/A129D mutant BonA was purified concurrently
as described above. Protein concentration was normalized to 3mg/ml, and 200ml was loaded onto a
Superdex S200 Increase 10/300 column equilibrated in 50mM Tris–200mM NaCl (pH 7.9) after 0, 24, and
72 h of incubation at 22°C. Chromatograms were analyzed based on known decamer and monomer
peaks, and the peak areas were calculated.
Differential scanning fluorimetry of wild-type mutant BonA. Fluorescence at 330 and 350nm and
light scattering of wild-type and mutant BonA were recorded as a function of temperature using a
Prometheus NanoDSF instrument, with a BonA concentration of 5mg/ml in 50mM Tris–200mM NaCl (pH 7.9).
Due to the lack of tryptophan residues in BonA, the fluorescence recorded resulted from tyrosine residues.
Protein crystallization, data collection, and structure solution. Purified BonA proteins were
screened for crystallization conditions using commercially available screens (;800 conditions). Crystals
grew from drops containing BonA-27N in medium composed of 0.2 M zinc acetate, 0.1 M sodium acetate, and
20% PEG 3350 (pH 4.5), and the crystals were optimized from this starting condition. The crystals were
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cryoprotected by increasing PEG 3350 concentration to 30% and flash cooled in liquid N2. Diffraction data
were collected at 100K at the Australian Synchrotron on selenomethionine-labeled crystals and processed in
the space group P3121 to 1.65Å. Heavy atom sites were located, phases were obtained using single-wave-
length anomalous dispersion (SAD), and the initial model was built using Autosol from the Phenix package
(60). Eight heavy atom sites were located; four of these sites were selenium, and four of these sites were zinc.
The BonA-N27 model was improved manually in Coot and refined using Phenix refine and Refmac (60–62).
Analysis of the BonA-27N crystal structure was performed using the Phenix and CCP4 packages, noncrystallo-
graphic interfaces were predicted using PISA (46, 60, 63).
Small-angle X-ray scattering. Small-angle X-ray scattering (SAXS) was performed using Coflow SEC-
SAXS at the Australian Synchrotron (64). Purified BonA and BonA-27N were analyzed at a preinjection
concentration of 10mg/ml. Scattering was collected over a q range of 0.0 to 0.3 Å21. A buffer blank for
each SEC-SAXS run was prepared by averaging 10 to 20 frames before or after protein elution.
Scattering data from peaks corresponding to BonA and BonA-27N were then buffer subtracted and
scaled across the elution peak and compared for interparticle effects. Identical curves (5–10) from elu-
tion were then averaged to provide curves for analysis. Data were analyzed using the PRIMUS package,
ScÅtter, and DAMMIF modeler (65).
Analytical ultracentrifugation. Sedimentation velocity (SV) determination was carried out in a
Beckman Coulter Optima analytical ultracentrifuge using an An-50 Ti 8-hole rotor. BonA-FL (370ml) at
concentrations ranging from 0.25 to 2mg/ml was loaded into a 12-mm path-length centerpiece and
centrifuged at 40,000 rpm for ;6 h at 20°C. Scans were collected every 20 s using absorbance optics (at
230, 240, and 280 nm, with a radial range of 5.8 to 7.2 cm and a radial step size of 0.005 cm). We used
50mM Tris–200mM NaCl (pH 7.9) as the buffer. Data were analyzed with SEDFIT using the continuous
c(s) distribution model (66). SEDNTERP was used to calculate the partial specific volume, the buffer den-
sity, and the viscosity at 15 and 20°C.
On-column cross-linking and negative-stain electron microscopy. To stabilize the BonA decamer
an “on-column” cross-linking method was used. Initially, 200ml of glutaraldehyde solution (0.05 to 0.5%
in dH2O) was injected to a preequilibrated Superdex 200 10/300 column in buffer (20mM HEPES,
150mM NaCl [pH 7.4]). The column was run at 0.25ml /min for 20min (5ml buffer). Subsequently, the
column flow was paused, and the injection loop was flushed using buffer, followed by injection of puri-
fied BonA (200ml at 10mg/ml). Subsequently, the column was run at 0.25ml/min, and 0.5-ml fractions
were collected. Collected fractions were immediately quenched by the addition of 50ml of 50mM Tris
(pH 7.5). The crosslinking efficiency was visualized by running the individual fractions on a 10% SDS gel,
and cross-linked fractions were flash-frozen for NS-EM analysis.
Native and cross-linked BonA were serially diluted in buffer (20mM HEPES, 150mM NaCl [pH 7.4]),
and 5ml was spotted onto freshly glow-discharged carbon-coated 200-mesh copper grids (Pelco), fol-
lowed by blotting to remove all but a thin film of protein solution. Blotted grids were fixed with the
tungsten-based Nano-W strain (Nanoprobes) by adding the stain to each grid, followed by 60 s of incu-
bation and blotting; this was repeated three times prior to air drying. The grids were imaged on a 120-
keV Tecnai Spirit G2 microscope (FEI) equipped with a 4 K FEI Eagle camera. Images were processed, par-
ticles were picked, and 2D classes were generated using the RELION package (v2.1) (67).
Data availability. The crystallographic coordinates and associated structure factors for BonA are
available at the Protein Data Bank (PDB) under accession code 6V4V. Small-angle X-ray scattering data
for BonA full-length and BonA-27N are available in the SASBDB with the accession codes SASDJW3 and
SASDJX3. The accession numbers of protein sequences used to construct the phylogenetic tree are pro-
vided in Table S1 in the supplemental material.
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